French Luxury Stock News

ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Sanofi Expands Respiratory Portfolio With Nuvaxovid Role And Lunsekimig Data

Sanofi has become the market authorization holder for Nuvaxovid, a non-mRNA COVID-19 vaccine, in Canada. The company reported positive phase 2 results for lunsekimig in respiratory conditions including asthma and chronic rhinosinusitis with nasal polyps. Sanofi (ENXTPA:SAN), trading at €81.02, sits at the center of two fresh respiratory health updates that expand its presence in vaccines and therapeutics. The stock shows a mixed return profile, with a 6.1% gain over the past 30 days and a...
ENXTPA:RMS
ENXTPA:RMSLuxury

A Look At Hermès International (ENXTPA:RMS) Valuation After Q1 2026 Revenue And Store Sales Growth

Hermès International Société en commandite par actions (ENXTPA:RMS) reported Q1 2026 revenue of €4.1b, up 6% at constant exchange rates, with double digit growth in the Americas, Japan and Europe excluding France. See our latest analysis for Hermès International Société en commandite par actions. The Q1 2026 update comes after a mixed year in the market, with the share price at €1,783.0, a 1 week share price return of 8.2%, but a 1 year total shareholder return decline of 23.4% and momentum...
ENXTPA:CDI
ENXTPA:CDILuxury

Christian Dior Grows In Q1 As Valuation And Share Trends Diverge

Christian Dior reported organic growth in the first quarter despite global economic and geopolitical disruptions. The company saw resilient performance in Asian and US markets while results varied across business segments. Recent product launches supported growth during a period that included conflict in the Middle East. For investors watching ENXTPA:CDI, the fresh update on organic growth comes with a mixed share price backdrop. Christian Dior trades at about €463.4, with a return of 4.3%...
ENXTPA:GET
ENXTPA:GETInfrastructure

Assessing Getlink (ENXTPA:GET) Valuation After Recent Share Momentum And Premium P/E Multiple

Recent share performance puts Getlink in focus Getlink (ENXTPA:GET) has drawn attention after a recent share move, with the stock showing a 0.2% gain over the past week and about 9% over the past month. See our latest analysis for Getlink. Zooming out from the recent move, the share price return sits at 8.7% over the past month and 23.1% over the past quarter, while the 1 year total shareholder return of 25.2% suggests momentum has been building over a longer stretch. If you are comparing...
ENXTPA:IPS
ENXTPA:IPSMedia

Top European Dividend Stocks To Watch In April 2026

As European markets rally following a U.S.-Iran ceasefire, investor sentiment is buoyed by the potential for reduced geopolitical tensions, with major indices like Germany’s DAX and France’s CAC 40 posting notable gains. In this environment of cautious optimism, dividend stocks can offer a compelling blend of income and stability, making them an attractive option for those seeking to navigate current market uncertainties while benefiting from consistent returns.
ENXTPA:ERF
ENXTPA:ERFLife Sciences

Is Eurofins Scientific (ENXTPA:ERF) Pricing In Its Recent 36% One-Year Share Price Jump?

For investors wondering whether Eurofins Scientific at €68.48 represents fair value or a potential mispricing opportunity, this article breaks down what the current price might be implying. The stock has posted returns of 5.3% over the last 7 days, 11.4% over 30 days, 10.5% year to date, and 36.5% over 1 year, which is likely to catch the eye of anyone tracking price momentum or shifting risk perceptions. Recent news coverage on Eurofins Scientific has focused on its role as a global testing...
ENXTPA:LI
ENXTPA:LIRetail REITs

Assessing Klépierre (ENXTPA:LI) Valuation After Leadership Changes At The Supervisory Board

Klépierre (ENXTPA:LI) is in focus after its Supervisory Board met on April 3, 2026, to honor late Chairman David Simon and implement immediate leadership changes affecting the board’s composition. See our latest analysis for Klépierre. The leadership update comes as Klépierre’s €35.2 share price has shown building momentum, with a 9.4% 1 month share price return and a 21.8% 1 year total shareholder return alongside a very large 5 year total shareholder return. If this board change has you...
ENXTPA:AKE
ENXTPA:AKEChemicals

Assessing Arkema (ENXTPA:AKE) Valuation After Recent Share Price Momentum And Earnings Multiple Stretch

Event context and recent share performance Arkema (ENXTPA:AKE) has drawn investor attention after recent share price moves, with the stock showing a 0.7% decline over the past day but gains over the past week, month, and the past 3 months. See our latest analysis for Arkema. While the share price has eased 0.7% over the last day, Arkema’s recent momentum is positive, with a 30 day share price return of 11.34% and a year to date share price return of 15.38%, in contrast to a 3 year total...
ENXTPA:PEUG
ENXTPA:PEUGDiversified Financial

A Look At Peugeot Invest (ENXTPA:PEUG) Valuation After Mixed Recent Share Price Performance

Peugeot Invest Société anonyme (ENXTPA:PEUG) at a glance Peugeot Invest Société anonyme (ENXTPA:PEUG) has drawn attention after a mixed return profile, with a small positive 1 year total return but weaker performance over the past 3 months and year to date. See our latest analysis for Peugeot Invest Société anonyme. Recent trading has been mixed, with a 7 day share price return of 3.01% and a 30 day share price return of 2.52% offset by a 90 day share price decline of 16.86%. At the same...
ENXTPA:PLX
ENXTPA:PLXDiversified Financial

Pluxee (ENXTPA:PLX) Valuation Check After Recent Share Price Rebound

Recent share performance and why Pluxee is on investors’ radar Pluxee (ENXTPA:PLX) has caught investor attention after a recent move in its share price, with the stock showing a 3.1% gain over the past day and 5.3% over the past week. Over the past month, Pluxee has returned 7.0%. Over the past 3 months it has declined 4.3%, and the one year total return sits at a 38.3% loss, which helps put the recent rebound into context for investors. See our latest analysis for Pluxee. That recent 7.0% 1...
ENXTPA:MC
ENXTPA:MCLuxury

LVMH Middle East Slowdown Highlights Regional Risk And Segment Resilience

LVMH Moët Hennessy Louis Vuitton (ENXTPA:MC) reported its first quarter business update, showing a material hit to Middle Eastern luxury demand linked to ongoing armed conflict in the region. The company flagged tangible revenue disruption and weaker mall traffic in key Gulf markets, which weighed on overall group organic growth. Core Fashion & Leather Goods underperformed, while Watches & Jewelry and several other regions, including parts of Asia and the US, showed more resilience. The...
ENXTPA:TE
ENXTPA:TEEnergy Services

Assessing Technip Energies (ENXTPA:TE) Valuation After New LNG And Steam Cracker Contract Wins

Technip Energies (ENXTPA:TE) has attracted fresh attention after announcing two sizeable project wins, including a Vietnamese steam cracker upgrade and a large authorization tied to a liquefied natural gas export facility in Louisiana. See our latest analysis for Technip Energies. The recent contract wins arrive as Technip Energies' share price trades at €39.68, with a 30-day share price return of 24.16% and a 1-year total shareholder return of 42.37%. This signals building momentum on top of...
ENXTPA:HO
ENXTPA:HOAerospace & Defense

Is It Too Late To Consider Thales (ENXTPA:HO) After Its Strong Multi‑Year Rally?

If you are wondering whether Thales at €265.60 is still fairly priced or starting to look stretched, the valuation picture is where you will want to focus next. The stock has been relatively stable over the last week with a 0.7% decline, sits 4.6% higher over the past month, and is up 13.0% year to date after a 6.8% return over the past year and a 99.2% gain across three years. These moves sit against a backdrop where investors are watching Thales for its position in aerospace and defense,...
ENXTPA:DSY
ENXTPA:DSYSoftware

Assessing Dassault Systèmes (ENXTPA:DSY) Valuation After New AI Virtual Twin Partnership In Cosmetics

Dassault Systèmes (ENXTPA:DSY) is back in focus after unveiling a collaboration with Groupe Rocher that applies its virtual twin and generative AI tools to cosmetic ingredient research and to improving formulation efficiency. See our latest analysis for Dassault Systèmes. The collaboration news lands at a time when Dassault Systèmes’ share price, now at €17.54, has a 1 day share price return of 4.31% but a 90 day share price return of 28.14% decline and a 1 year total shareholder return of...
ENXTPA:CCN
ENXTPA:CCNBanks

Undiscovered Gems In Europe To Watch This April 2026

As European markets rally with the STOXX Europe 600 Index up 3.05% amid easing geopolitical tensions and a temporary ceasefire between the U.S. and Iran, investors are cautiously optimistic about regional growth prospects despite looming concerns over potential stagflationary pressures. In this environment, identifying promising small-cap stocks requires a focus on companies with strong fundamentals that can navigate economic uncertainties while capitalizing on emerging opportunities in their...
ENXTPA:RNO
ENXTPA:RNOAuto

Is Renault (ENXTPA:RNO) Offering An Opportunity After Recent Share Price Weakness?

Investors may be wondering whether Renault at €30.70 is pricing in too much pessimism or leaving room on the table for value focused investors. The share price has moved 2.0% over the last 7 days and 7.8% over the last month. However, the year to date return of a 15.6% decline and 1 year return of a 26.4% decline show the stock has been through a tougher patch. Recent headlines have focused on how traditional automakers are repositioning around electrification, software and partnerships,...
ENXTPA:PLNW
ENXTPA:PLNWSoftware

Assessing Planisware SAS (ENXTPA:PLNW) Valuation After Full-Year Revenue And Net Income Growth

Why Planisware SAS (ENXTPA:PLNW) is Back on Investors’ Radar Planisware SAS (ENXTPA:PLNW) has attracted fresh attention after releasing full year 2025 results, with revenue of €198.02 million and net income of €50 million, compared with €183.45 million and €42.73 million a year earlier. See our latest analysis for Planisware SAS. Despite the latest 1-day and 7-day share price returns of 2.60% and 2.74%, Planisware SAS trades at €14.98, with a 30-day share price return of a 5.55% decline and a...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Airbus (ENXTPA:AIR) Valuation Check As First Quarter Deliveries Hit Lowest Level Since 2009

Airbus (ENXTPA:AIR) is back in focus after first quarter aircraft deliveries fell 16% to 114 units, the lowest since 2009. This has put renewed attention on supply chain constraints and its full year delivery ambitions. See our latest analysis for Airbus. At a share price of €170.46, Airbus has seen a 3.22% 7 day share price return, while its 90 day share price return of 22.59% and year to date share price return of 16.32% decline contrast with a 1 year total shareholder return of 25.16%...
ENXTPA:DEC
ENXTPA:DECMedia

Assessing JCDecaux (ENXTPA:DEC) Valuation After Winning Western Sydney Airport Advertising Contract

JCDecaux (ENXTPA:DEC) has secured a long term contract to develop and operate a premium digital out of home advertising network at Western Sydney International Airport, giving investors fresh context for assessing the stock. See our latest analysis for JCDecaux. The new Western Sydney International Airport contract comes after a high profile global campaign for Céline Dion, and arrives as JCDecaux’s share price shows a 19.71% 90 day return and 26.46% year to date share price return, while the...
ENXTPA:STMPA
ENXTPA:STMPASemiconductor

Is It Too Late To Consider STMicroelectronics (ENXTPA:STMPA) After Its Sharp 1 Year Rally?

If you are wondering whether STMicroelectronics is attractively priced or starting to look expensive, the recent share performance makes that question especially relevant. The stock last closed at €33.84, with returns of 16.3% over 7 days, 18.3% over 30 days, 44.4% year to date, 90.8% over 1 year, negative 23.7% over 3 years and 10.7% over 5 years. These mixed time frame returns give you two very different stories: a strong recent run and a weaker multi year profile. This is why context...
ENXTPA:IVA
ENXTPA:IVABiotechs

A Look At Inventiva (ENXTPA:IVA) Valuation After Weaker Full Year 2025 Earnings

Inventiva (ENXTPA:IVA) is in focus after reporting full year 2025 earnings, with sales of €4.48 million, a net loss of €354.14 million and a basic loss per share from continuing operations of €1.9. See our latest analysis for Inventiva. The earnings release appears to have weighed on sentiment in the short term, with a 30 day share price return of 12.48% and a 90 day share price return of 7.65%, even as the year to date share price return is 11.87% and the 1 year total shareholder return is...